Clinical Trial Update: Fimasartan Optimal Reduction Targeting Elevated Blood Pressure: the FORTE Study

View source ↗

Summary

The FORTE study evaluated fimasartan for optimal blood pressure reduction in hypertension. The trial status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension

Drugs mentioned

• Fimasartan (fimasartan)

Snippet

Sponsor: Boryung Pharmaceutical Co., Ltd | Conditions: Hypertension | Status: COMPLETED